Biotech
Angeion (ANGN) shares soared 80% Monday after the tiny medical diagnostic systems maker swung to a fiscal third-quarter profit.
The St. Paul, Minn., company made $655,000, or 17 cents a share, for the quarter ended July 31. That reverses the year-ago continuing operations loss of $77,000, or 2 cents a share. Sales rose to $8.8 million from $6.1 million a year earlier. Shares rose $3.40 to $7.56.TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn MoreTo begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,435.57 | 1,315.89 | 2,830.09 | 15.81 |
Oil *
101.98
|
|
UP
15.71 |
UP
2.57 |
DOWN
7.27 |
DOWN
0.44 |
10 Yr
1.58%
SPDR Gold
151.82
|
|
+0.13%
|
+0.20%
|
-0.26%
|
-2.71%
|
Data delayed 20 minutes |
Connect with TheStreet